🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Effectiveness of iPACK and Adductor Canal Blocks on Patients Undergoing Arthroscopic Knee Surgery

RecruitingNAAges 18 Years - 50 YearsAllSakarya University
NCT07002580 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Arthroscopic knee surgery is one of the most commonly performed procedures in orthopedic surgery. More than 50% of patients experience moderate to severe pain after the operation. Inadequate postoperative pain control and poor recovery quality can negatively impact physiotherapy protocols, prolong hospital stays, and consequently lead to cognitive dysfunction, systemic infections, and increased healthcare costs. Therefore, reducing postoperative pain and improving recovery quality are of great importance. In our clinic, a variety of analgesic techniques are routinely employed as part of a multimodal analgesia approach for patients undergoing arthroscopic knee surgery. One of these techniques is the simultaneous application of the IPACK block and the adductor canal block. In this study, we aim to evaluate the effectiveness of these blocks on postoperative recovery quality in patients un

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged between 18 and 50 years, * Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology * Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification Exclusion Criteria: * Coagulopathy * ASA IV-V patients * Uncooperable patients * Patients who refuses to participate in study * Patients who takes chronic pain treatments
💊

What it tests

  • IPACK and adductor canal block with Bupivacaine 0.25%
  • Spinal Anesthesia with Bupivacaine
📍

Where

1 site
Sakarya University Training and Research Hospital
Sakarya, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy